Similarly, Li et al. [193] demonstrated, using an in vitro model of tumor-derived DCs from patients with non-small cell lung cancer (NSCLC), that the TME alters DC functionality by simultaneously suppressing canonical NF-κB and STAT3 signaling, leading to dysregulated transcription of downstream genes [193]. This evidence concerns the gene NFKB1 and neoplasm.